OSA Clinical Trial - Validity of a Vibrating Postural Device for

Status Completed

Clinical Trial Summary

The objective of the study is validity of the effectiveness of a vibrating postural device in reduce the respiratory events (Apnea-Hypopnea Index-AHI) in patients with positional Obstructive Sleep Apnea (OSA).

Clinical Trial Description

PURPOSE:

The objective of the study is validity of the effectiveness of a vibrating postural device in reduce the respiratory events (Apnea-Hypopnea Index-AHI) in patients with positional Obstructive Sleep Apnea (OSA).

The postural device is a vibratil device of 5x3 cm and a weight of about 30 grams integrating an accelerometer, a vibration and other sensors. The device is placed on the patient's forehead and when the device detects that the patient is in the supine position for 30 seconds or more, it starts a vibration, with increasing intensity, which ceases when the patient moves to lateral.

METHODOLOGY: DESIGN: A multicenter, randomized parallel study controlled by placebo. It will include patients with diagnosis of positional OSA in the Sleep Units of the Hospital Universitario Araba and Hospital Arnau de Vilanova de Lleida. These patients will be randomized to three groups: Group A: General recommendation not sleeping in supine position; Group B: General recommendation not sleeping in supine position and the device without any activation (placebo); Group C: General recommendation not sleeping in supine position and the device activated (intervention group).

Patients will undergo a basal conventional polysomnography (PSG) and after 12 weeks of treatment. In addition all patients will be visited at 1, 4, 8 and 12 weeks.

PRIMARY OUTCOME: Validity of the effectiveness of a vibrating postural device in reduce the respiratory events in patients with positional Obstructive Sleep Apnea . SECONDARY OUTCOMES: To determine the effectiveness of the device for: 1) To reduce the time spent in supine position; 2)To maintain the quantity and the quality of sleep; 3) The side effects ; 4) Reduction of snoring; 5) Cost-effectiveness analysis. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03336515
Study type	Interventional
Source	Hospital Universitario Araba
Contact
Status	Completed
Phase	N/A
Start date	September 1, 2015
Completion date	July 27, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05404438` - Mouth Breathing Habits Improvement Intervention	N/A
Recruiting	`NCT05960175` - Impact of Patient Involvement in Alerts Management of Telemonitoring CPAP	N/A
Recruiting	`NCT05813275` - Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study)	Phase 3
Completed	`NCT05075668` - Efficacy of HFNC as an Alternative to CPAP Therapy in Surgical Patients With Suspected Moderate to Severe OSA	N/A
Completed	`NCT05881512` - Early Feasibility Study of Transcutaneous Upper Airway Stimulation in Obstructive Sleep Apnea	N/A
Not yet recruiting	`NCT05944965` - Pharyngeal Muscle Control Mechanisms of Atomoxetine-plus-oxybutynin in Obstructive Sleep Apnea	Phase 1/Phase 2
Completed	`NCT02387476` - Non-Inferiority Study of the FRESCA Mask Versus Existing CPAP Mask for Treatment of Obstructive Sleep Apnea	N/A
Not yet recruiting	`NCT06058052` - Prevalence of OSA in Patients of ILD
Recruiting	`NCT03721445` - Could HRV be a Valuable Predictor for CPAP Adherence?
Completed	`NCT03172130` - Sham CPAP vs. Straight CPAP for Chronic Cough	N/A
Recruiting	`NCT06320795` - Prospective Study for the Clinical Validation of the Soundi Wearable Medical Device	N/A
Completed	`NCT01717339` - Sleep Apnea and Vascular Function	N/A
Completed	`NCT00772044` - Randomized Study of Provent Versus Sham Device to Treat Obstructive Sleep Apnea	Phase 4
Recruiting	`NCT06400615` - Study That Tests AD109 in Patients Taking GLP-1 Drugs	Phase 2
Completed	`NCT02438137` - Dimethyl Fumarate for Obstructive Sleep Apnea	N/A
Completed	`NCT01672606` - Effect of Rocuronium on the Acute Hypoxic Ventilatory Response in Patients With Obstructive Sleep Apnea	N/A
Not yet recruiting	`NCT06110962` - Detecting Heart Rate, Respiration, and Sleep With the Sleeptracker-AI Under-mattress Monitor
Completed	`NCT05060133` - Changes of the Upper Airway Volume After Orthognathic Surgery
Completed	`NCT03196583` - Efficacy of a Novel MAD in OSA	N/A
Not yet recruiting	`NCT03933046` - The Association Between Sleep Duration and Sleep Disorders and Proteinuria in Children	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Validity of a Vibrating Postural Device for the Treatment of Positional Obstructive Sleep Apnea (Postural) — POSTURAL

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms